Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
3 Mar 2021, 07:00
4D pharma management will present and meet with investors at three upcoming investor conferences…
1 Mar 2021, 07:00
4D pharma announces the appointment of Paul Maier as Non-Executive Director of the Board. Mr Maier…
1 Mar 2021, 07:00
4D pharma announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the…
26 Feb 2021, 07:00
4D pharma to list ADSs on NASDAQ in conjunction with the merger agreement between 4D pharma and…
16 Feb 2021, 07:00
Duncan Peyton, Chief Executive Officer of 4D pharma, will participate in Cantor Fitzgerald's virtual…
8 Feb 2021, 07:00
4D pharma announces clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt,…
3 Feb 2021, 07:00
4D pharma announces progress on activities in its development program for lead immuno-oncology…
21 Jan 2021, 08:00
4D today announces its participation in the Microbiome Movement Drug Development Summit - Europe,…
18 Dec 2020, 08:25
A landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson’s disease…
26 Nov 2020, 07:00
Merger completion and NASDAQ listing expected in Q1 2021.
US listing will support and accelerate…
9 Nov 2020, 13:00
MRx0518 demonstrates upregulation of key immune biomarkers associated with anti-cancer activity in…
5 Nov 2020, 12:00
4D Pharma to Host Virtual KOL Event Reviewing New Data Presented at the SITC Annual Meeting 2020…
22 Oct 2020, 07:00
4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its…
14 Oct 2020, 07:00
7 Oct 2020, 07:00
4D pharma announces topline results from Blautix® Phase II BHT-II-002 trial in IBS-C and IBS-D
